GSA Capital Partners’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $557K | Sell |
|
|||||
|
2025
Q3 | $880K | Buy |
|
|||||
|
2025
Q2 | $432K | Buy |
|
|||||
|
2025
Q1 | $221K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $93K | Sell |
|
|||||
|
2023
Q3 | $308K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $462K | Sell |
|
|||||
|
2022
Q4 | $420K | Sell |
|
|||||
|
2022
Q3 | $1.19M | Sell |
|
|||||
|
2022
Q2 | $1.04M | Buy |
|
|||||
|
2022
Q1 | $186K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $185K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $149K | Sell |
|
|||||
|
2019
Q1 | $420K | Buy |
|